Xunming Cui

Capital Markets

• Advised Big Tree Cloud International Group Limited, a company devoted to the development, production and sales of personal care products and other consumer goods in China, in its $500 million merger with special purpose acquisition company Plutonian Acquisition Corp., and subsequent listing on the NASDAQ.
• Advised Shanghai Fosun Pharmaceutical, a leading Chinese health care group, in the following transactions:

- participation as a major shareholder in the de-SPAC transaction of the Delaware digital health company Butterfly Network on the NASDAQ; the total transaction value exceeded $3 billion;

- in the $1.44 billion sale of stakes in United Family Healthcare along with TPG to New Frontier Corporation, a NASDAQ-listed SPAC and concurrent to the Fosun Group’s equity acquisition of New Frontier Corporation to become its second-largest equity holder; this deal was awarded “Deal of the Year 2019” by China Business Law Journal;

- formation of a strategic alliance with the NASDAQ-listed German company BioNTech to develop and commercialize a vaccine that prevents COVID-19 infections using BioNTech’s mRNA vaccine candidate BNT162, and a proposed equity investment in BioNTech; and

- participation in the $1.6 billion take-private transaction for New Frontier Health Corporation by a buyer consortium consisting of New Frontier Public Holding, Vivo Capital Fund IX, Fosun, Goldman Sachs, Warburg Pincus and other investors.

• Advised Ping An Group in the following transactions:

- investment in Autohome, a leading automobile trading and information website listed on Nasdaq, and participation in its secondary listing in Hong Kong; and

- divestment from MOGU, a NYSE-listed company.

• Advised MultiMetaVerse, in its $300 million de-SPAC transaction and subsequent listing on the Nasdaq. MultiMetaVerse is an animation and entertainment company devoted to establishing an open community for its global users by providing high-quality entertainment experiences.
• Advised Hunan Yongxiong Asset Management, a Chinese debt recovery company in its proposed IPO in the United States.
• Advised an Automation Technology Company listed on NASDAQ, in its proposed follow-on public offer.
• Advised a vehicle manufacturing company based in China, in its pre-IPO restructuring, private placement and proposed IPO in the United States.
• Advised a pioneering hydrogen fuel cell-powered-vehicle company in China, in its proposed business combination with a NASDAQ-listed special purpose acquisition company.

Other Corporate Matters

• Advised Apex Group’s founding team in its equity sales transaction as part of the Swiss publicly listed company Kuehe and Nagel International AG’s acquisition of the Apex Group, a leading logistics company.
• Advised Fosun Group, in its participation in the proposed restructuring of Thomas Cook, a tourism service company.
• Advised an online platform company based in China, in its complex cross-border restructuring and financing.